Orphan Drug Development
Thank you for getting in touch.
If you have not heard from us in the next 48 hours, do not hesitate to call us on
UK +44 (0)115 974 9000 / US +1-800-769-3518
At Quotient Sciences we have supported over 50 development programs for rare disease in the past 5 years. Our extensive formulation know-how, clinical pharmacology expertise, coupled with our agile and flexible approach to clinical and commercial manufacturing, makes us the ideal partner.
From pre-formulation and formulation development through clinical development and scale up for commercial manufacturing we provide an end-to-end solution for the development of orphan drug products. Our extensive expertise and capabilities for orphan drug development includes:
Pre-formulation and API characterisation.
Formulation and process development.
First-in-human clinical testing and acceleration into POC trials.
Bespoke clinical manufacturing and supply (Phase I-III) of drug products into patient trials.
Rapid scale-up and commercial manufacturing of low-volume products.